TriangleNCT00085735 · OUTCOME
Post-treatment Neurocognitive Function as Measured by the Estimated Full-scale IQ (FSIQ) by CSI Group Within Time Window 3 (49 - 72 Months Post Diagnosis)
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEAN
- Unit
- Scores on a scale
- Interval / dispersion
- Standard Deviation
- Time frame
- 49 - 72 months post diagnosis
What was measured
Post-treatment neurocognitive function was assessed. Full-scale IQ (FSIQ) is a representative measurement for neurocognitive function. FSIQ was measured by IQ tests. Assessments within the time window, from eligible and evaluable patients are reported. The time window is 49-72 months post diagnosis, only the assessments before progression date were reported. The Range of FSIQ is 50-150. A higher FSIQ is better.
Analysis population: Eligible and evaluable patients are reported.
Groups in this outcome
Low-dose Craniospinal Radiation (LDSCI)
Includes eligible patients 3-7 years of age without anaplastic histology or evidence of disseminated or ERD based on central review and randomized to one of the LDCSI arms (Treatment Arms I or II) and with a post-treatment TSH value.
Standard-dose Craniospinal Radiation (SDCSI)
Includes eligible patients 3-7 years of age without anaplastic histology or evidence of disseminated or ERD based on central review and randomized to one of the SDCSI arms (Treatment Arms III or IV) and with a post-treatment TSH value.
| Group | Source count |
|---|---|
| Low-dose Craniospinal Radiation (LDSCI) | 23 |
| Standard-dose Craniospinal Radiation (SDCSI) | 22 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Low-dose Craniospinal Radiation (LDSCI) | 90.5 | 15.4 | Not reported | Not reported | Not reported |
| Standard-dose Craniospinal Radiation (SDCSI) | 86.4 | 13.5 | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- spread
- 15.4
- value
- 90.5
- group Id
- OG001
- spread
- 13.5
- value
- 86.4
- denoms
- counts
- group Id
- OG000
- value
- 23
- group Id
- OG001
- value
- 22
- units
- Participants
- description
- Post-treatment neurocognitive function was assessed. Full-scale IQ (FSIQ) is a representative measurement for neurocognitive function. FSIQ was measured by IQ tests. Assessments within the time window, from eligible and evaluable patients are reported. The time window is 49-72 months post diagnosis, only the assessments before progression date were reported. The Range of FSIQ is 50-150. A higher FSIQ is better.
- dispersion Type
- Standard Deviation
- groups
- description
- Includes eligible patients 3-7 years of age without anaplastic histology or evidence of disseminated or ERD based on central review and randomized to one of the LDCSI arms (Treatment Arms I or II) and with a post-treatment TSH value.
- id
- OG000
- title
- Low-dose Craniospinal Radiation (LDSCI)
- description
- Includes eligible patients 3-7 years of age without anaplastic histology or evidence of disseminated or ERD based on central review and randomized to one of the SDCSI arms (Treatment Arms III or IV) and with a post-treatment TSH value.
- id
- OG001
- title
- Standard-dose Craniospinal Radiation (SDCSI)
- param Type
- MEAN
- population Description
- Eligible and evaluable patients are reported.
- reporting Status
- POSTED
- time Frame
- 49 - 72 months post diagnosis
- title
- Post-treatment Neurocognitive Function as Measured by the Estimated Full-scale IQ (FSIQ) by CSI Group Within Time Window 3 (49 - 72 Months Post Diagnosis)
- type
- SECONDARY
- unit Of Measure
- Scores on a scale
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice